Company / Operating Cash Flow per Share
Veracyte, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$1.75
FY2025
5-year range
-$0.54 / $1.75
FY2021-FY2025
Trend
+71.0%
vs FY2024
Sector context
#93 of 155
Health Care
What the data says
At $1.75, Veracyte, Inc.'s operating cash flow per share ranks #93 of 155 in the Health Care sector. Operating Cash Flow per Share has increased for 4 consecutive years, from $-0.54 in FY2021 to $1.75 in FY2025.
Based on SEC 10-K filings.
1.75 in FY2025 with a 3-year CAGR of +154.8%.
Improved from $0.61 to $1.75 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +154.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#93 of 155 in Health CareTop 60% of 155This company $1.75 Sector average $6.77
▼
-74.1% below sector average
Key checks
Key Insights
- Veracyte, Inc.'s operating cash flow per share has grown for 4 consecutive years.
- In FY2025, operating cash flow per share increased 71.0% year-over-year.
- Ranks #93 out of 155 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.75 | +71.0% |
| FY2024 | $1.02 | +66.8% |
| FY2023 | $0.61 | +480.1% |
| FY2022 | $0.11 | +119.5% |
| FY2021 | -$0.54 | -177.6% |
| FY2020 | -$0.20 | -147.4% |
| FY2019 | -$0.08 | +80.3% |
| FY2018 | -$0.40 | +43.5% |
| FY2017 | -$0.71 | +29.9% |
| FY2016 | -$1.01 | +15.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026